Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,004,973

« Back to Dashboard
Patent 6,004,973 protects AFINITOR, ZORTRESS, and AFINITOR DISPERZ, and is included in three NDAs. There have been zero Paragraph IV challenges on Afinitor and Zortress

Protection for AFINITOR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,004,973

Title: Pharmaceutical compositions comprising rafamycin coprecipitates
Abstract:Disclosed are pharmaceutical compositions containing solid dispersions in the form of co-precipitates, which solid dispersions contain rapamycin and a carrier medium, and methods of treatment utilizing such pharmaceutical compositions.
Inventor(s): Guitard; Patrice (Hegenheim, FR), Haeberlin; Barbara (Riehen, CH), Link; Rainer (Staufen, DE), Richter; Friedrich (Grenzach-Wyhlen, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:08/981,952
Patent Claim Types:
see list of patent claims
Composition; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 10th percentile
Forward Citations: 4th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
TABLET;ORAL022334-003Jul 9, 2010RXNo6,004,973*PEDJan 12, 2017Y
TABLET;ORAL022334-001Mar 30, 2009RXNo6,004,973*PEDJan 12, 2017Y
TABLET;ORAL022334-004Mar 30, 2012RXNo6,004,973*PEDJan 12, 2017Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,004,973

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9514397Jul 14, 1995
United Kingdom9515025Jul 21, 1995
PCT Information
PCT FiledJuly 12, 1996PCT Application Number:PCT/EP96/03066
PCT Publication Date:February 06, 1997PCT Publication Number: WO97/03654

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.